Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Tonn, J. C."" wg kryterium: Autor


Wyświetlanie 1-13 z 13
Tytuł:
Mutational signature of extracranial meningioma metastases and their respective primary tumors.
Autorzy:
Biczok A; Department of Neurosurgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany. .; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany. .
Thorsteinsdottir J; Department of Neurosurgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany.
Karschnia P; Department of Neurosurgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany.
Ruf VC; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany.
Tonn JC; Department of Neurosurgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany.
Herms J; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany.
Schichor C; Department of Neurosurgery, Ludwig-Maximilians-University Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany.
Dorostkar MM; Center for Neuropathology and Prion Research, Ludwig-Maximilians-University Munich, Munich, Germany.; German Cancer Research Center (DKFZ), German Cancer Consortium (DKTK), Partner Site Munich, Heidelberg, Germany.; Department of Pathology, University Clinic of St. Pölten, Karl Landsteiner University of Health Sciences, St. Pölten, Austria.
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2023 Jan 14; Vol. 11 (1), pp. 12. Date of Electronic Publication: 2023 Jan 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Meningeal Neoplasms*/genetics
Meningeal Neoplasms*/pathology
Meningioma*/genetics
Meningioma*/pathology
Neoplasm Metastasis*/genetics
Humans ; Homozygote ; Mutation ; Retrospective Studies ; Sequence Deletion
Czasopismo naukowe
Tytuł:
TSPO PET, tumour grading and molecular genetics in histologically verified glioma: a correlative F-GE-180 PET study.
Autorzy:
Unterrainer M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Fleischmann DF; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Vettermann F; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Ruf V; Department of Neuropathology, LMU Munich, Munich, Germany.
Kaiser L; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Nelwan D; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Lindner S; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Brendel M; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Wenter V; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.
Stöcklein S; Department of Radiology, University Hospital, LMU Munich, Munich, Germany.
Herms J; Department of Neuropathology, LMU Munich, Munich, Germany.
Milenkovic VM; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Rupprecht R; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Tonn JC; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurosurgery, University Hospital, LMU Munich, Munich, Germany.
Belka C; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Niyazi M; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.
Albert NL; Department of Nuclear Medicine, University Hospital, LMU Munich, Munich, Germany. .; German Cancer Consortium (DKTK), Partner Site Munich, and German Cancer Research Center (DKFZ), Heidelberg, Germany. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2020 Jun; Vol. 47 (6), pp. 1368-1380. Date of Electronic Publication: 2019 Sep 05.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Brain Neoplasms*/diagnostic imaging
Brain Neoplasms*/genetics
Glioma*/diagnostic imaging
Glioma*/genetics
Carbazoles ; Humans ; Molecular Biology ; Mutation ; Neoplasm Grading ; Neoplasm Recurrence, Local ; Positron-Emission Tomography ; Receptors, GABA
Czasopismo naukowe
Tytuł:
DNA methylation, transcriptome and genetic copy number signatures of diffuse cerebral WHO grade II/III gliomas resolve cancer heterogeneity and development.
Autorzy:
Binder H; Interdisciplinary Centre for Bioinformatics, Universität Leipzig, Härtelstr. 16-18, 04107, Leipzig, Germany. .
Willscher E; Interdisciplinary Centre for Bioinformatics, Universität Leipzig, Härtelstr. 16-18, 04107, Leipzig, Germany.
Loeffler-Wirth H; Interdisciplinary Centre for Bioinformatics, Universität Leipzig, Härtelstr. 16-18, 04107, Leipzig, Germany.
Hopp L; Interdisciplinary Centre for Bioinformatics, Universität Leipzig, Härtelstr. 16-18, 04107, Leipzig, Germany.
Jones DTW; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Pediatric Glioma Research Group, German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
Pfister SM; Hopp Children's Cancer Center Heidelberg (KiTZ), Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.; Division of Pediatric Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Department of Pediatric Oncology, Hematology and Immunology, Heidelberg University Hospital, Im Neuenheimer Feld 430, 69120, Heidelberg, Germany.
Kreuz M; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Härtelstraße 16-18, 04107, Leipzig, Germany.
Gramatzki D; Department of Neurology, University Hospital and University Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.
Fortenbacher E; Interdisciplinary Centre for Bioinformatics, Universität Leipzig, Härtelstr. 16-18, 04107, Leipzig, Germany.
Hentschel B; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Härtelstraße 16-18, 04107, Leipzig, Germany.
Tatagiba M; Clinic for Neurosurgery, Tübingen University Hospital, Hoppe-Seyler-Straße 3, 72076, Tübingen, Germany.
Herrlinger U; Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, Bonn, Germany.
Vatter H; Division of Clinical Neurooncology, Department of Neurology, University Hospital Bonn, Bonn, Germany.
Matschke J; Institute of Neuropathologie, University Clinic Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Westphal M; Department of Neurosurgery, University Clinic Hamburg-Eppendorf, Martinistraße 52, 20246, Hamburg, Germany.
Krex D; Department of Neurosurgery, Technical University Dresden, Fetscherstraße 74, 01307, Dresden, Germany.
Schackert G; Department of Neurosurgery, Technical University Dresden, Fetscherstraße 74, 01307, Dresden, Germany.
Tonn JC; Department of Neurosurgery, Ludwig Maximilians University Munich and German Cancer Consortium (DKTK), partner site Munich, Marchioninistraße 15, D-81377, Munich, Germany.
Schlegel U; Department of Neurology, University Hospital Knappschaftskrankenhaus Bochum-Langendreer, In der Schornau 23-25, 44892, Bochum, Germany.
Steiger HJ; Clinic for Neurosurgery, University Düsseldorf, Moorenstr. 5, 40225, Düsseldorf, Germany.
Wick W; Clinical Cooperation Unit Neurooncology, German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.; Neurology Clinic and National Center for Tumor Diseases, University Hospital Heidelberg, Im Neuenheimer Feld 400, 69120, Heidelberg, Germany.
Weber RG; Department of Human Genetics, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.
Weller M; Department of Neurology, University Hospital and University Zurich, Frauenklinikstrasse 26, 8091, Zurich, Switzerland.
Loeffler M; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Härtelstraße 16-18, 04107, Leipzig, Germany.
Pokaż więcej
Źródło:
Acta neuropathologica communications [Acta Neuropathol Commun] 2019 Apr 25; Vol. 7 (1), pp. 59. Date of Electronic Publication: 2019 Apr 25.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Dosage*
Transcriptome*
Brain Neoplasms/*genetics
DNA Methylation/*genetics
Glioma/*genetics
Brain Neoplasms/complications ; Computational Biology ; Epigenesis, Genetic ; Humans ; Neoplasm Grading ; Tumor Microenvironment/genetics ; World Health Organization
Czasopismo naukowe
Tytuł:
Comparison of F-FET PET in high grade glioma: a double-tracer pilot study.
Autorzy:
Unterrainer M; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Fleischmann DF; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Diekmann C; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Vomacka L; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Lindner S; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Vettermann F; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Brendel M; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Wenter V; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Ertl-Wagner B; Institute of Clinical Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Herms J; Department of Neuropathology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Wetzel C; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Rupprecht R; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Tonn JC; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Belka C; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Niyazi M; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Albert NL; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. .; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2019 Mar; Vol. 46 (3), pp. 580-590. Date of Electronic Publication: 2018 Sep 22.
Typ publikacji:
Comparative Study; Journal Article
MeSH Terms:
Carbazoles*/metabolism
Glioma/*diagnostic imaging
Glioma/*pathology
Positron-Emission Tomography/*methods
Tyrosine/*analogs & derivatives
Adult ; Aged ; Biological Transport ; Brain Neoplasms/diagnostic imaging ; Brain Neoplasms/genetics ; Brain Neoplasms/pathology ; Female ; Glioma/genetics ; Humans ; Magnetic Resonance Imaging ; Male ; Middle Aged ; Neoplasm Grading ; Pilot Projects ; Polymorphism, Genetic ; Radioactive Tracers ; Receptors, GABA/genetics ; Tumor Burden ; Tyrosine/metabolism
Czasopismo naukowe
Tytuł:
Biological tumour volumes of gliomas in early and standard 20-40 min F-FET PET images differ according to IDH mutation status.
Autorzy:
Unterrainer M; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Winkelmann I; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Suchorska B; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Giese A; Department of Neuropathology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Wenter V; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Kreth FW; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Herms J; Department of Neuropathology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tonn JC; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Albert NL; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. .; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2018 Jul; Vol. 45 (7), pp. 1242-1249. Date of Electronic Publication: 2018 Feb 27.
Typ publikacji:
Journal Article
MeSH Terms:
Tumor Burden*
Brain Neoplasms/*diagnostic imaging
Glioma/*diagnostic imaging
Adult ; Aged ; Brain Neoplasms/genetics ; Brain Neoplasms/therapy ; Female ; Glioma/genetics ; Glioma/therapy ; Humans ; Male ; Middle Aged ; Mutation ; Positron-Emission Tomography ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Correction to: Biological tumour volumes of gliomas in early and standard 20-40 min F-FET PET images differ according to IDH mutation status.
Autorzy:
Unterrainer M; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Winkelmann I; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Suchorska B; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Giese A; Department of Neuropathology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Wenter V; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Kreth FW; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Herms J; Department of Neuropathology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Bartenstein P; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Tonn JC; Department of Neurosurgery, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.
Albert NL; Department of Nuclear Medicine, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. .; German Cancer Consortium (DKTK), Partner Site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany. .
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2018 Jun; Vol. 45 (6), pp. 1078.
Typ publikacji:
Journal Article; Published Erratum
Czasopismo naukowe
Tytuł:
TSPO PET for glioma imaging using the novel ligand F-GE-180: first results in patients with glioblastoma.
Autorzy:
Albert NL; Department of Nuclear Medicine, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany. .; German Cancer Consortium (DKTK), partner site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany. .; 'Munich Cluster of Systems Neurology (SyNergy)', Munich, Germany. .
Unterrainer M; Department of Nuclear Medicine, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Fleischmann DF; German Cancer Consortium (DKTK), partner site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, LMU Munich, Munich, Germany.
Lindner S; Department of Nuclear Medicine, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Vettermann F; Department of Nuclear Medicine, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Brunegraf A; Department of Nuclear Medicine, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Vomacka L; Department of Nuclear Medicine, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Brendel M; Department of Nuclear Medicine, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Wenter V; Department of Nuclear Medicine, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
Wetzel C; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Rupprecht R; Department of Psychiatry and Psychotherapy, University of Regensburg, Regensburg, Germany.
Tonn JC; German Cancer Consortium (DKTK), partner site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Neurosurgery, LMU Munich, Munich, Germany.
Belka C; German Cancer Consortium (DKTK), partner site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, LMU Munich, Munich, Germany.
Bartenstein P; Department of Nuclear Medicine, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.; German Cancer Consortium (DKTK), partner site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.; 'Munich Cluster of Systems Neurology (SyNergy)', Munich, Germany.
Niyazi M; German Cancer Consortium (DKTK), partner site Munich; and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Department of Radiation Oncology, LMU Munich, Munich, Germany.
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2017 Dec; Vol. 44 (13), pp. 2230-2238. Date of Electronic Publication: 2017 Aug 19.
Typ publikacji:
Journal Article
MeSH Terms:
Carbazoles*
Positron-Emission Tomography*
Glioblastoma/*diagnostic imaging
Glioblastoma/*metabolism
Receptors, GABA/*metabolism
Female ; Humans ; Ligands ; Male ; Middle Aged ; Pilot Projects ; Recurrence
Czasopismo naukowe
Tytuł:
Expression of BARHL1 in medulloblastoma is associated with prolonged survival in mice and humans.
Autorzy:
Pöschl J; Center for Neuropathology, Ludwig-Maximilians-University, Munich, Germany.
Lorenz A
Hartmann W
von Bueren AO
Kool M
Li S
Peraud A
Tonn JC
Herms J
Xiang M
Rutkowski S
Kretzschmar HA
Schüller U
Pokaż więcej
Źródło:
Oncogene [Oncogene] 2011 Nov 24; Vol. 30 (47), pp. 4721-30. Date of Electronic Publication: 2011 May 23.
Typ publikacji:
Journal Article
MeSH Terms:
Cerebellar Neoplasms/*mortality
Homeodomain Proteins/*physiology
Medulloblastoma/*mortality
Nerve Tissue Proteins/*physiology
Repressor Proteins/*physiology
Adolescent ; Adult ; Animals ; Cerebellar Neoplasms/pathology ; Child ; Child, Preschool ; Female ; Hedgehog Proteins/physiology ; Homeodomain Proteins/analysis ; Humans ; Infant ; Male ; Medulloblastoma/pathology ; Mice ; Nerve Tissue Proteins/analysis ; Repressor Proteins/analysis
Czasopismo naukowe
Tytuł:
Cervicothoracic intradural arachnoid cyst misdiagnosed as motor neuron disease.
Autorzy:
Sämann PG; Max Planck Institute of Psychiatry, Kraepelinstrasse 2-10, 80804 Munich, Germany.
Himmerich H
Merl T
Erös C
Müller MB
Tonn JC
Buchwald B
Pokaż więcej
Źródło:
Case reports in medicine [Case Rep Med] 2010; Vol. 2010, pp. 261657. Date of Electronic Publication: 2010 Jun 10.
Typ publikacji:
Case Reports
Raport
Tytuł:
O-(2-[18F]fluoroethyl)-L-tyrosine PET for monitoring the effects of convection-enhanced delivery of paclitaxel in patients with recurrent glioblastoma.
Autorzy:
Pöpperl G; Department of Nuclear Medicine, Klinikum Grosshadern, University of Munich, Marchioninistrasse 15, 81377 Munich, Germany. />Goldbrunner R
Gildehaus FJ
Kreth FW
Tanner P
Holtmannspötter M
Tonn JC
Tatsch K
Pokaż więcej
Źródło:
European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2005 Sep; Vol. 32 (9), pp. 1018-25. Date of Electronic Publication: 2005 May 05.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Brain Neoplasms/*diagnostic imaging
Brain Neoplasms/*drug therapy
Glioblastoma/*diagnostic imaging
Glioblastoma/*drug therapy
Neoplasm Recurrence, Local/*diagnostic imaging
Neoplasm Recurrence, Local/*drug therapy
Paclitaxel/*administration & dosage
Tyrosine/*analogs & derivatives
Antineoplastic Agents/administration & dosage ; Convection ; Drug Delivery Systems/methods ; Female ; Humans ; Infusions, Intralesional/methods ; Male ; Middle Aged ; Positron-Emission Tomography/methods ; Prognosis ; Radiopharmaceuticals ; Reproducibility of Results ; Sensitivity and Specificity ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Molecular genetic analysis of the TP53, PTEN, CDKN2A, EGFR, CDK4 and MDM2 tumour-associated genes in supratentorial primitive neuroectodermal tumours and glioblastomas of childhood.
Autorzy:
Kraus JA; Department of Neurology, University of Bonn, Medical Center, Bonn, Germany.
Felsberg J
Tonn JC
Reifenberger G
Pietsch T
Pokaż więcej
Źródło:
Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2002 Aug; Vol. 28 (4), pp. 325-33.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cerebellar Neoplasms/*genetics
Glioblastoma/*genetics
Molecular Biology/*methods
Neuroectodermal Tumors, Primitive/*genetics
Adolescent ; Child ; Child, Preschool ; Chromosomes, Human, Pair 10/genetics ; Chromosomes, Human, Pair 17/genetics ; Female ; Genes, p53/genetics ; Genetic Markers ; Humans ; Infant ; Infant, Newborn ; Loss of Heterozygosity ; Male ; Mutation ; PTEN Phosphohydrolase ; Phosphoric Monoester Hydrolases/genetics ; Tumor Suppressor Proteins/genetics
Czasopismo naukowe
Tytuł:
Human medulloblastomas lack point mutations and homozygous deletions of the hSNF5/INI1 tumour suppressor gene.
Autorzy:
Kraus JA; Department of Neurology, University of Bonn Medical Center, Sigmund-Freud-Strasse 25, D-53105 Bonn, Germany.
Oster C
Sörensen N
Berthold F
Schlegel U
Tonn JC
Wiestler OD
Pietsch T
Pokaż więcej
Źródło:
Neuropathology and applied neurobiology [Neuropathol Appl Neurobiol] 2002 Apr; Vol. 28 (2), pp. 136-41.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Gene Deletion*
Homozygote*
Point Mutation*
Cerebellar Neoplasms/*genetics
DNA-Binding Proteins/*genetics
Genes, Tumor Suppressor/*physiology
Medulloblastoma/*genetics
Adolescent ; Adult ; Base Sequence/genetics ; Cerebellar Neoplasms/pathology ; Child ; Child, Preschool ; Chromosomal Proteins, Non-Histone ; Female ; Gene Dosage ; Humans ; Infant ; Infant, Newborn ; Male ; Medulloblastoma/pathology ; Middle Aged ; Polymerase Chain Reaction/methods ; Polymorphism, Genetic ; Polymorphism, Single-Stranded Conformational ; SMARCB1 Protein ; Transcription Factors ; Tumor Cells, Cultured
Czasopismo naukowe
    Wyświetlanie 1-13 z 13

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies